688105.SH
Nanjing Vazyme Biotech Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 22.51
−7.14%Next report
Analyst consensus
- Next report date
- Oct 26, 2026
- EPS estimate
- —
- Revenue estimate
- CNY 975.0M
Latest reported
- Last report date
- Aug 31, 2026
- EPS actual
- CNY 0.04
- EPS estimate
- —
- Revenue actual
- CNY 379.8M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 31, 2026 | — | CNY 0.04 | — | CNY 379.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 26, 2026